Du Zhong

Eucommia ulmoides Oliv.

Also known as: Eucommia bark(English) 杜仲(Chinese)

Tochū杜仲 トチュウ Duchung杜仲 두충 Đỗ trọng Tu Chung

Updated October 23, 2026 · Not yet clinically reviewed

Du Zhong
Photo: Salix, CC BY-SA 4.0, via Wikimedia Commons

Safety at a glance

Note

3 recorded drug interactions

Note

Contraindications or side effects are listed

No rule in our tables for this herb: pregnancy, breastfeeding, incompatible pairs (十八反 / 十九畏), herb–drug, dose ceiling. This is not a safety clearance.
Not graded —

No toxicity grade is recorded. Most herbs in the catalogue carry none.

Traditional Chinese Medicine

Category
tonifying
Temperature
Warm
Taste
Sweet
Channels
Liver,Kidney

Functions

Nourishes Liver and Kidney Yin; Strengthens the Sinews and Bones; Calms the Fetus; Lowers Blood Pressure

Traditional uses

Du Zhong (eucommia bark) is a warm, sweet herb primarily used to tonify the Liver and Kidney, strengthen the sinew and bones, and calm the fetus. It is one of the most important herbs for chronic lower back and knee pain, weakness, and stiffness arising from Liver-Kidney deficiency — conditions that commonly develop with aging. Du Zhong also lowers blood pressure and is frequently used in modern Chinese medicine for hypertension associated with rising Liver Yang over a deficient Kidney foundation.

Western herbalism

Properties: tonic, anti-inflammatory

Pharmacological effects

  • Hypotensive: I.v. decoction lowered blood pressure in anesthetized dogs (longer with >1 g/kg); oral extracts lowered BP in hypertensive dogs; aqueous extract lowered BP and heart rate in rats via direct vasodilation; pinoresinol diglucoside considered the main active principle.
  • Hypolipidemic: Leaf extract fed to high-fat-diet rats for 35 days suppressed rises in serum cholesterol, triacylglycerol, VLDL and LDL without affecting HDL.
  • Sedative and analgesic: Decoction i.p. reduced spontaneous activity and prolonged barbiturate sleep in mice and inhibited writhing and hot-plate pain.
  • Anti-inflammatory: Decoction and ethanolic extract inhibited egg white paw edema in rats; thymic atrophy in young mice suggested enhanced adrenocortical function.
  • Reticuloendothelial phagocytosis: Oral decoction enhanced carbon clearance and macrophage phagocytosis in (hydrocortisone-treated) mice.
  • Diuretic: Extracts were diuretic in anesthetized dogs, even in dogs tolerant to the hypotensive effect.
  • Uterus: Decoction and ethanolic extract antagonized pituitrin- and acetylcholine-induced contraction of isolated rat and rabbit uteri; mild stimulation of cat uterus.

Source: Zhu YP. Chinese Materia Medica: Chemistry, Pharmacology and Applications. Harwood Academic, 1998, p. 602.

Formulas using this herb

36 of 36 formulas

Botanical

Eucommia ulmoides is a medium-sized deciduous tree in its own monotypic family Eucommiaceae, native to central China and now cultivated in many temperate regions. It typically grows 15-20 meters tall with a straight trunk, greyish-brown furrowed bark, and a spreading crown. The alternate leaves are elliptic to ovate, 8-16 cm long, with acuminate tips and serrate margins; uniquely, when a leaf is torn slowly, fine, white, elastic threads of latex (gutta-percha) stretch between the broken halves. The tree is dioecious, with small inconspicuous petalless flowers appearing before the leaves in spring, followed on female trees by flat, winged samaras. In TCM, the inner bark (Du Zhong) is harvested from trees about ten to fifteen years old and used as a sweet, warm herb that tonifies the liver and kidneys and strengthens sinews and bones.

Family
Eucommiaceae
Pharmaceutical name
Cortex Eucommiae
Parts used
bark
Plant type
tree
Native region
Guizhou, Henan, Hubei, Shaanxi, Sichuan, Yunnan

Constituents

Pinoresinol di-O-beta-D-glucopyranoside (pinoresinol diglucoside)

Lignan diglucoside · about 0.5% of dried bark, markedly higher than in any other part of the tree; not detected at all in the leaf

The bark-specific marker lignan and the compound to which the antihypertensive activity of Eucommiae Cortex is most often attributed. The only controlled human trial of the bark used an aqueous extract standardised to 8% pinoresinol diglucoside. Because this lignan is undetectable in the leaf, it is the single clearest chemical line between Du Zhong and Du Zhong Ye.

Geniposidic acid

Iridoid glucoside · reported up to about 6.7% in the bark of branches, against roughly 1.5% in the leaf; a seven-cultivar survey found 9.6-230.2 mg/g in bark

A major iridoid of the bark that contributes to the drug's blood-pressure-lowering and bone-protective activity in animal models, with part of the antihypertensive effect in spontaneously hypertensive rats attributed to it alongside improved renal blood flow. Content varies several-fold between cultivars and with harvest timing, so bark potency is not uniform.

Aucubin

Iridoid glucoside · present in bark, but highly variable between cultivars; a seven-cultivar survey reported 6.6-368.6 mg/g of dried bark

An iridoid shared with the leaf that carries most of the anti-inflammatory and osteoblast-stimulating activity reported for Eucommia extracts. Aucubin is chemically labile and readily hydrolysed, so the content of a stored or badly dried bark is not that of fresh material.

Chlorogenic acid

Phenylpropanoid (caffeoylquinic acid) · 2.7-37.5 mg/g of dried bark in a seven-cultivar survey, against 11.4-120.0 mg/g in the leaf of the same trees

Present in the bark but at a small fraction of the leaf level, so chlorogenic-acid-based rationales belong properly to Du Zhong Ye rather than to the bark. It contributes antioxidant and mild vasorelaxant activity.

Eucommia gum (gutta-percha, trans-1,4-polyisoprene)

Polyterpene · about 10-12% of the bark, against 2-3% of the leaf

The elastic polymer responsible for the silvery threads that stretch across the break when good Du Zhong bark is snapped, which is the classical quality criterion for the drug and the practical way to tell bark from leaf material. It is not water-soluble and is pharmacologically inert, so it does not enter a decoction, but its abundance is why the bark is dense and hard to powder.

Drug interactions

Antihypertensive drugs, particularly beta-blockers

Moderate · Additive blood-pressure lowering, with hypotension, dizziness or bradycardia possible · Evidence level: Probable

In the only controlled human trial of the bark, an aqueous extract standardised to 8% pinoresinol diglucoside at 1 g three times daily for two weeks reduced 24-hour ambulatory blood pressure by an average of 7.5/3.9 mmHg. The same study showed the extract reduced isoproterenol-stimulated lipolysis in a human fat cell assay from 2.67 to 1.4 times the buffer control, which the authors interpreted as beta-adrenergic blocking activity. Animal work adds nitric-oxide-mediated vasorelaxation and renin-angiotensin system effects. So the bark is not merely an incidental hypotensive, it appears to share a mechanism with prescribed beta-blockers.

Clinical note: Check blood pressure and pulse before and two weeks after adding Du Zhong to a patient on antihypertensives, and be alert for symptomatic hypotension or bradycardia in a patient already on a beta-blocker. It is not a substitute for antihypertensive medication and should not be used to justify reducing one.

Beta-agonist bronchodilators (e.g. salbutamol, formoterol)

Theoretical · Possible blunting of beta-agonist response · Evidence level: Theoretical

The beta-adrenergic blocking activity demonstrated for the standardised bark extract in a human adipocyte assay is the same pharmacology that makes beta-blockers a caution in asthma. No study has tested Eucommia bark against a beta-agonist in the airway, and the potency in adipocytes says nothing quantitative about bronchial beta-2 receptors, so this is an inference from mechanism only.

Clinical note: There is no evidence of harm, but in a patient with brittle asthma who needs reliable reliever response, prefer another Kidney-and-sinew tonic or monitor peak flow when starting the bark.

Nephrotoxic drugs (e.g. NSAIDs, aminoglycosides, calcineurin inhibitors)

Theoretical · Possible additive renal injury with prolonged high-dose use · Evidence level: Theoretical

A 13-week rodent toxicology study of Eucommia ulmoides extract found a dose-dependent rise in nephrotoxicity indices with histological change in renal tissue, which resolved five weeks after stopping the lower dose (11.2 g/kg raw-plant equivalent) but persisted at the higher dose (56 g/kg). The same study found no genotoxicity and a maximum tolerated dose of at least 168 g/kg, roughly 1260 times the human clinical dose, so acute risk at ordinary doses is very low; the concern is confined to long-term high-dose exposure. The study reports the extract without specifying which plant part it was made from.

Clinical note: At Pharmacopoeial decoction doses over normal treatment courses this is not a practical concern. For patients taking concentrated Eucommia extracts for months, particularly alongside NSAIDs, check renal function periodically and avoid open-ended high-dose use.

Dosage

FormAmountFrequencyNotes
decoction6–10 gDaily
中国药典 2020 【用法与用量】6~10g。 【性味与归经】甘,温。归肝、肾经。 — Chinese Pharmacopoeia 2020, quoted verbatim; route and cautions preserved. Replaces a cleared category-filler value.

Dui yao: classical pairings

Du Zhong + Bu Gu Zhi补骨脂

Kidney yang is warmed while the lower back and knees are strengthened.

Kidney-deficiency low back pain.

Core pair of a classical formula — Qing E Wan, Tai Ping Hui Min He Ji Ju Fang

Du Zhong + Xu Duan续断

Liver and kidney are tonified and sinews and bones strengthened while the blood vessels are unblocked, securing the Chong and Ren.

Low back pain from kidney deficiency, uterine bleeding and threatened miscarriage.

Named pairing — Lü Jingshan, Shi Jinmo Dui Yao

Evidence

Study design on record, not certainty of outcome.

Randomized controlled trial
1
In vitro / animal
1

A clinical trial testing the safety and efficacy of a standardized Eucommia ulmoides Oliver bark extract to treat hypertension

Greenway F, Liu Z, Yu Y, Gupta A · Alternative Medicine Review · 2011 · RCT

Randomized controlled trial · Not yet verified

Three linked studies of an aqueous bark extract standardised to 8% pinoresinol di-beta-D-glucoside. Study 1 randomised 24 adults with blood pressure of 120-160/80-100 mmHg to 500 mg three times daily for eight weeks and found no toxicity and no difference in blood pressure between groups. Study 3 randomised 30 similar adults to 1 g three times daily for two weeks and found a reduction of 7.5/3.9 mmHg on 24-hour ambulatory monitoring (P less than 0.008). Study 2, a human fat cell assay, showed the extract at 0.5% w/v reduced isoproterenol-stimulated lipolysis from 2.67 to 1.4 times the buffer control (P less than 0.001), indicating beta-adrenergic blocking activity. The lower dose was therefore ineffective and only the doubled dose lowered blood pressure; both were well tolerated. Predates DOI registration for this journal, so cited by PubMed record.

Metabolite Profiles, Bioactivity, and HPLC Fingerprint of Different Varieties of Eucommia ulmoides Oliv.: Towards the Utilization of Medicinal and Commercial Chinese Endemic Tree

Dong Wu, Danmeng Yu, Yujia Zhang, Juane Dong, Dengwu Li, Dongmei Wang · Molecules · 2018 · in vitro

In vitro / animal · Not yet verified

HPLC profiling of leaf and bark from seven Eucommia ulmoides varieties. Pinoresinol diglucoside was detected only in bark (23.0-53.6 mg/g) while rutin, hyperoside and astragalin were detected only in leaf, establishing the two drugs as chemically distinct rather than interchangeable. Chlorogenic acid was far higher in leaf (11.4-120.0 mg/g) than bark (2.7-37.5 mg/g); aucubin and geniposidic acid occurred in both with wide between-cultivar variation. The authors concluded that different varieties suit bark versus leaf use.

doi:10.3390/molecules23081898

Safety

Contraindications

Its use is cautious in patients with vigorous fire due to yin deficiency.

Source: Xi S, Gong Y. Essentials of Chinese Materia Medica and Medical Formulas. Academic Press/Elsevier, 2017, pp. 344–356.

Side effects

  • Low toxicity in animals; long-term i.p. decoction in dogs produced only mild renal tubular epithelial degeneration; no blood or liver/kidney abnormalities in rats given oral decoction or alcoholic extract.

Source: Zhu YP. Chinese Materia Medica: Chemistry, Pharmacology and Applications. Harwood Academic, 1998, p. 602.

Cultural and historical

Shen Nong Ben Cao Jing · Han dynasty

Records Du Zhong for pain of the lumbar region and spine, supplementing the centre, boosting essence and qi, hardening the sinews and bones and strengthening the will. The bark is the part described; the leaf has no entry here.

Ming Yi Bie Lu · Southern dynasties (Tao Hongjing, c. 500 CE)

Expands the bark's indications toward the lower back and knees, and toward foot weakness, consolidating its role as the Kidney-and-sinew drug rather than a general tonic.

Ben Cao Gang Mu · Ming dynasty (Li Shizhen, 1596)

Gives the quality criterion still used in the trade, that good Du Zhong shows abundant white elastic threads when the bark is snapped. Those threads are the 10-12% gutta-percha of the bark, so the classical grading rule is in effect a test of a bark-specific constituent and cannot be applied to leaf material.

References

  1. Lichuang Huang, Qiang Lyu, Wanying Zheng, Qiao Yang, Gang Cao. Traditional application and modern pharmacological research of Eucommia ulmoides Oliv.. Chinese Medicine. 2021 doi:10.1186/s13020-021-00482-7
  2. Yun Li, Xiangyang Kang. Advances in research on the bioactive compounds and genetic improvement of Eucommia ulmoides. Medicinal Plant Biology. 2024 doi:10.48130/mpb-0024-0028
  3. Ying Yan, Hui Zhao, Cuihua Chen, Lisi Zou, Xunhong Liu, Chuan Chai, Chengcheng Wang, Jingjing Shi, Shuyu Chen. Comparison of Multiple Bioactive Constituents in Different Parts of Eucommia ulmoides Based on UFLC-QTRAP-MS/MS Combined with PCA. Molecules. 2018 doi:10.3390/molecules23030643
  4. Xiaomei Luo, Jiashuo Wu, Zhuangzhuang Li, Weiyi Jin, Fangqing Zhang, Hong Sun, Yue Shi. Safety evaluation of Eucommia ulmoides extract. Regulatory Toxicology and Pharmacology. 2020 doi:10.1016/j.yrtph.2020.104811
© Verscienta Health — use subject to the API terms at https://verscienta.com/developers/api; educational reference, not medical advice